Equitable Access to Better Care
The Founding Team
Lynda Chin, MD
CEO, Co-Founder
Formerly Founding Chair for the Department of Genomic Medicine @ MD Anderson Cancer Center. Formerly Chief Innovation Officer for Health Affairs @ University of Texas System Expertise in Genomics, Data, Applications of technology and AI in medicine.
Pam Sharma, MD/PhD
Co-Founder
Professor, Department of Immunology & Genitourinary Medical Oncology. Scientific Director, Immunotherapy Platform Co-Director, Parker Institute for Cancer Immunotherapy@ MD Anderson Cancer Center. Expertise in IO therapy and development.
Keith Flaherty, MD
Co-Founder
Director of Clinical Research @ Massachusetts General Hospital. Professor @ Harvard Medical School. Expertise in targeted therapy and IO in melanomas.
James Allison, PhD
Founding Advisor
Professor and Chair, Immunology & Exec Director, Immunotherapy Platform. Co-Director, Parker Institute for Cancer Immunotherapy@ MD Anderson Cancer Center. Father of Immuno-oncology and Pioneer of IO therapy in cancer.